Person

Back to overview

Mach Francois

Gender Male
Institute Service de Cardiologie Département de Médecine Interne Hôpitaux Universitaires de Genève
Show all

Projects as responsible applicant

Responsible applicant Institution of higher education Start End date Funding scheme

Anti-inflammatory treatment to reduce atherosclerosis and acute myocardial ischemia
Mach Francois University of Geneva - GE 01.01.2005 31.12.2007 Project funding

Role of TGF-ß1-deficient B cells and follicular regulatory T cells in atherosclerosis
Mach Francois University of Geneva - GE 01.04.2018 31.03.2022 Project funding

Selective anti-inflammatory treatments to reduce post-infarction heart failure
Mach Francois University of Geneva - GE 01.01.2011 31.12.2013 Project funding

Long-term Benefit of the Multi-Center, Multi-Dimensional Secondary Prevention Program in Patients With Acute Coronary Syndromes
Mach Francois University of Geneva - GE 01.01.2016 31.12.2018 Project funding

Anti-inflammatory approaches to reduce ischemia-reperfusion injury during acute myocardial infarction
Mach Francois University of Geneva - GE 01.01.2008 31.12.2010 Project funding

Endothelial Electrical Signaling in a murine model of Atherosclerosis. Identification of potential cannabinoid targets for treatment of the disease
Mach Francois University of Geneva - GE 01.07.2014 31.12.2017 SCOPES

A: Role of vascular wall chemokines in the pathogenesis of athe- rosclerosis. B: Immunomodulation: A new role for HMG-CoA reducta-se inhibitors (Statins) and PPAR activators as potential new...
Mach Francois University of Geneva - GE 01.01.2002 31.12.2004 Project funding

Role of B cell subsets in atherosclerotic plaque vulnerability and peripheral tissue ischemic injury
Mach Francois University of Geneva - GE 01.05.2014 30.04.2017 Project funding

Role of Vascular Wall Chemokines in the Pathogenesis of Atherosclerosis.(zu SCORE A)
Mach Francois University of Geneva - GE 01.01.1999 31.12.2001 Project funding

Role of Vascular Wall Chemokines in the Pathogenesis of Atherosclerosis. (SCORE A)
Mach Francois University of Geneva - GE 01.01.1999 31.12.2005 Ambizione

Projects as co-applicant

Responsible applicant Institution of higher education Start End date Funding scheme

ADRIE - antiplatelet drug resistances ans ischemic events
Fontana Pierre University of Geneva - GE 01.04.2007 30.09.2008 Project funding

Inflammation and acute coronary syndrome (ACS) - novel strategies for prevention and clinical management
Lüscher Thomas F. University of Zurich - ZH 01.02.2012 31.01.2015 SPUM

Exercise training and family-based behavioural treatment in pre-pubertal obese children and their mother: A randomized controlled trial
Beghetti Maurice University of Geneva - GE 01.07.2008 30.06.2011 Project funding

Role of visfatin on inflammatory atherosclerotic vulnerability for ischemic stroke
Montecucco Fabrizio University of Geneva - GE 01.04.2011 31.03.2014 Project funding

Inflammation and acute coronary syndrome (ACS) - novel strategies for prevention and clinical management
Lüscher Thomas F. University of Zurich - ZH 01.02.2009 31.01.2012 SPUM

Relationship between increasing body weight, endocannabinoids, leptin and coronary circulatory disfunction
Schindler Thomas Hellmut University of Geneva - GE 01.02.2009 31.01.2012 Project funding

ER Niacin/laropiprant impact on cardiovascular markers and atheroprogression in HIV-infected individuals on cART: the NILACH trial
Calmy Alexandra University of Geneva - GE 01.01.2012 31.12.2015 Project funding (special)

Projects as project partner

Responsible applicant Institution of higher education Start End date Funding scheme

Enoxaparin for primary thromoprophylaxis in ambulatory patients with coronavirus: the multicenter randomized controlled ovid trial
Kucher Nils University of Zurich - ZH 01.09.2020 30.06.2023 NRP 78 Covid-19

Risk of Clonal Hematopoiesis of Indeterminate Potential in Patients with Acute Coronary Syndromes - Linking Mutagenesis and Inflammation with Atherothrombosis
Matter Christian Matthias R. University of Zurich - ZH 01.10.2020 30.09.2023 Project funding

-